Los Angeles, February 6, 2026 – Ispire Technology Inc. (NASDAQ: ISPR), a leader in the development and commercialization of vaporization technology and precise dosing, today announced its financial results for the second quarter of fiscal year 2026, ended December 31, 2025.

**Financial Highlights for Q2 FY2026** * Revenue was $20.3 million, compared to $41.8 million in the second quarter of fiscal 2025. * Gross profit was $3.5 million, compared to $7.7 million in the prior-year period. * Gross margin was 17.1%, compared to 18.5% in Q2 FY2025. * Total operating expenses were $10.3 million, down from $15.1 million in Q2 FY2025. * Net loss was $6.6 million, or $0.12 per share, an improvement from a net loss of $8.0 million, or $0.14 per share, in the same quarter last year.

"This quarter marks an inflection point for Ispire following a year of cost reduction and customer quality optimization efforts. We believe the coming quarters will see revenue growth, stable cash flow, and continued profit improvement. We are confident we have laid a solid foundation for the company's future success," stated Michael Wang, Co-CEO of Ispire.

"In Q2 FY2026, we remained focused on prioritizing high-quality revenue and adhering to a disciplined, planned strategy for sustainable growth. This is particularly evident in our ongoing efforts to reduce net accounts receivable, which have yielded significant results. During the quarter, we reduced net accounts receivable by 19.5% to $37.9 million, an improvement from $47.0 million at the end of fiscal 2025," Michael added.

"We continue to build important foundations in our core business areas, including enhancing production capacity in Malaysia in preparation for a full ramp-up in FY2026. Momentum for our proprietary G-Mesh technology continues to build, with several large and mid-sized nicotine product manufacturers in discussions to evaluate its application in next-generation vaping devices. We are also actively pursuing potential licensing and partnership opportunities. Furthermore, our IKE Tech joint venture is making steady progress globally, collaborating with regulators in Europe, Southeast Asia, and the Middle East to support the broad adoption of age-verification technology as a safer industry standard."

"In the United States, while most adult consumers prefer flavored e-vapor products, nearly all such products are not FDA-authorized and are sold through illegal channels. We welcome increased federal enforcement against illicit trade but believe truly effective regulation must be paired with establishing a legal, FDA-authorized market for flavored e-vapor products. Ispire, through IKE, is a key participant in building this legal market, utilizing our technology to prevent underage access, ensure product authenticity, and provide safe, tamper-resistant solutions. This aligns with the macro tailwind from the FDA's public stance, which since October 2025 has clearly stated that age-verification technology is necessary for flavored product approval. Through our IKE joint venture, we possess leading, convenient technology in this area and look forward to fully capitalizing on this opportunity in due course," Michael concluded.

Jay Yu, Chief Financial Officer of Ispire, commented, "The second quarter of fiscal 2026 demonstrates the continued progress we are making in strengthening our financial foundation. Through rigorous cost control, operating expenses decreased year-over-year from $15.1 million to $10.3 million, highlighting the effectiveness of our efficiency initiatives. As of December 31, 2025, our net accounts receivable decreased to $37.9 million from $47.0 million as of June 30, 2025, reflecting our continued strategic focus on higher-quality customers. These actions support enhanced financial flexibility and underpin long-term, sustainable value creation."

**Detailed Q2 FY2026 Financial Results** Revenue for the second quarter was $20.3 million, compared to $41.8 million in the prior-year period. The decrease was primarily due to the company's strategic shift in its customer base, phasing out lower-quality cannabis customers, which impacted total product sales.

Gross profit for the quarter was $3.5 million, compared to $7.7 million a year ago. Gross margin was 17.1%, down from 18.5% in Q2 FY2025, primarily due to a product mix shift, with a lower proportion of sales from higher-margin products during the three months ended December 31, 2025.

Total operating expenses for Q2 FY2026 were $10.3 million, compared to $15.1 million in the year-ago quarter.

Net loss for the quarter was $6.6 million, or a loss of $0.12 per share, compared to a net loss of $8.0 million, or a loss of $0.14 per share, in Q2 FY2025.

As of December 31, 2025, Ispire held cash and cash equivalents of $17.6 million and had working capital of $3.5 million.

**Earnings Conference Call** The company will host a conference call on Friday, February 6, 2026, at 10:10 PM Beijing Time (9:10 AM ET) to discuss the financial results. Ispire Technology's management team will host the call, followed by a question-and-answer session.

**About Ispire Technology Inc.** Ispire Technology Inc. is engaged in the research, design, commercialization, sales, marketing, and distribution of branded vaping products. The company owns or has licenses from affiliates for over 200 invention/design patents worldwide. Ispire's products are marketed under the Aspire brand and are sold globally primarily through its distribution network. The company currently sells its vaping hardware in the U.S., Canada, Germany, and South Africa.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially. Factors that could cause or contribute to such differences are detailed in the company's filings with the U.S. Securities and Exchange Commission. Ispire undertakes no obligation to update forward-looking statements.

**Investor Relations Contact:** KCSA Strategic Communications Phil Carlson 212-896-1233 ispire@kcsa.com

**Public Relations Contact:** Ellen Mellody 570-209-2947 EMellody@kcsa.com